Gregory Scott Stein
Tulane University is actively seeking companies interested in commercializing novel constructs which effectively induce apoptosis in cancer cells. The novel approach employs two caspases to achieve a synergistic effect, resulting in a more substantial level of cell death in the targeted cancer cells.
This technology has been tested extensively in vitro and in vivo in a mouse model, with results strongly supporting the anti-cancer applications. Human trials are in development. Laboratory work is ongoing to produce more effective species of these constructs.
Tulane Technology Transfer and Intellectual Property Development, New Orleans, LA 70112 504-988-6962 email@example.com